Diabetic emergencies: hypoglycemia, DKA, glucagon administration, and clinical first aid¶

Diabetic emergencies represent acute, life-threatening disruptions of glucose homeostasis. The human brain depends almost entirely on continuous delivery of circulating blood glucose to fuel cellular metabolism. When blood sugar drops precipitously (hypoglycemia), neuroglycopenic starvation triggers rapid confusion, combativeness, seizures, coma, and permanent encephalopathy within minutes.

Conversely, severe insulin deficiency causes glucose to accumulate to toxic levels in the bloodstream (hyperglycemia), precipitating profound osmotic dehydration, life-threatening metabolic acidosis, and multiorgan failure over hours or days.

Responders must master the rapid differentiation of these crises, execute the evidence-based Rule of 15, deploy emergency glucagon formulations, and understand the universal field safety rule: when in doubt, always treat for low blood sugar.

Critical emergency triage priorities¶

If an individual with diabetes displays altered mental status, sweating, or acute distress, execute these chronological life-saving steps immediately:

Glucose homeostasis: insulin versus counter-regulatory hormones¶

Under normal physiological conditions, human blood glucose is maintained within a narrow physiological window between 3.9 and 5.6 mmol/L (70 and 99 mg/dL) while fasting, and under 7.8 mmol/L (140 mg/dL) postprandially:

                  [Blood Glucose Elevates Post-Meal]
                                  |
                                  v
                [Pancreatic Beta Cells Secrete Insulin]
                                  |
            +---------------------+---------------------+
            |                                           |
            v                                           v
[Facilitates GLUT4 Translocation]           [Inhibits Hepatic Gluconeogenesis]
Drives glucose into muscle & adipose cells   Halts glycogen breakdown in liver
                                  |
                                  v
                  [Blood Glucose Returns to Baseline]
                                  |
                                  v
                  [Blood Glucose Drops Below Normal]
                                  |
                                  v
    [Alpha Cells & Adrenals Release Glucagon, Epinephrine, Cortisol]
                                  |
                                  v
    [Hepatic Glycogenolysis & Gluconeogenesis Elevate Serum Glucose]

Type 1 versus Type 2 diabetes pathology¶

• Type 1 Diabetes Mellitus (T1D): An autoimmune disease characterized by lymphocytic destruction of pancreatic beta cells, resulting in absolute insulin deficiency. Patients depend on daily exogenous insulin injections or continuous subcutaneous insulin infusion pumps to survive. Unchecked, T1D progresses rapidly to Diabetic Ketoacidosis (DKA).
• Type 2 Diabetes Mellitus (T2D): Characterized by progressive peripheral insulin resistance coupled with relative secretory defects. Managed through diet, exercise, oral anti-hyperglycemic agents (metformin, sulfonylureas, SGLT2 inhibitors), and injectable GLP-1 receptor agonists or insulin. Severe decompensation typically manifests as Hyperosmolar Hyperglycemic State (HHS).

Hypoglycemia: the rapid crisis¶

Hypoglycemia is an acute medical emergency that develops in minutes. It occurs when the circulating concentration of insulin exceeds the available carbohydrate pool, driving serum glucose below 3.9 mmol/L (70 mg/dL).

Common etiologies of acute hypoglycemia¶

• Inadvertent administration of excessive insulin doses.
• Accidental administration of rapid-acting mealtime insulin instead of long-acting basal insulin.
• Skipping or delaying scheduled meals after taking insulin or sulfonylurea medications.
• Unplanned, prolonged physical exertion without carbohydrate supplementation.
• Alcohol consumption, which inhibits hepatic gluconeogenesis and blocks glycogen conversion.

The two distinct symptom phases¶

Symptoms develop in two successive neurological phases as glucose levels fall:

[Blood Glucose Drops Below 3.9 mmol/L (70 mg/dL)]
                        |
                        v
[Phase 1: Autonomic & Sympathoadrenal Surge]
- Epinephrine & norepinephrine flood circulation
- Profuse cold sweating (diaphoresis), pallor, trembling hands
- Sinus tachycardia, palpitations, intense physiological hunger
                        |
                        v
[Blood Glucose Drops Below 3.0 mmol/L (54 mg/dL)]
                        |
                        v
[Phase 2: Neuroglycopenic Cerebral Starvation]
- Cortical neurons starved of energetic ATP
- Disorientation, irritability, sudden belligerent behavior
- Slurred speech, ataxia, diplopia, hemiparesis (mimics acute stroke)
- Generalized tonic-clonic seizures, profound coma, irreversible brain death

Hypoglycemia unawareness¶

In individuals who have lived with diabetes for multiple decades or who experience frequent low blood sugar events, autonomic warning systems degrade. The adrenal glands fail to release epinephrine at low thresholds, completely eliminating the warning sweating, shaking, and tachycardia. These individuals jump directly from apparent normal function into sudden neuroglycopenic stupor, seizures, or collapse without warning.

Field management of hypoglycemia: the Rule of 15¶

For conscious individuals who are oriented and able to swallow without coughing or choking, execute the standardized Rule of 15:

Administer 15 to 20 grams of Fast-Acting Simple Carbohydrate
                              |
                              v
      Wait 15 Minutes (Do not administer extra food yet)
                              |
                              v
         Re-test Capillary Blood Glucose with Meter
                              |
            +-----------------+-----------------+
            |                                   |
   [Glucose < 3.9 mmol/L (70 mg/dL)]   [Glucose >= 3.9 mmol/L (70 mg/dL)]
            |                                   |
Repeat 15 grams fast-acting sugar      Provide complex carbohydrate snack
Wait another 15 minutes & re-test      (Bread, crackers, peanut butter, meal)

Approved fast-acting carbohydrate sources (15 to 20 grams)¶

Administer simple, rapidly absorbable sugars:

• 120 milliliters (4 fluid ounces / half a cup) of commercial fruit juice (orange or apple juice).
• 120 milliliters (4 fluid ounces / half a cup) of regular, non-diet soda.
• 3 to 4 commercial glucose chewable tablets.
• 1 tube of commercial oral glucose gel (15 grams).
• 5 to 6 hard candies or jelly beans chewed thoroughly.
• 1 tablespoon of table sugar or honey dissolved in water.

What to avoid during acute hypoglycemia¶

• Do Not Consume High-Fat Sweets: Avoid chocolate bars, pastries, donuts, whole milk, and ice cream during the initial 15-minute rescue window. High concentrations of dietary fat delay gastric emptying, slowing the absorption of glucose through the intestinal wall and leaving the brain starved of sugar for up to an hour.
• Do Not Over-Treat: Consuming an entire carton of juice, multiple sodas, and candy bars causes severe rebound hyperglycemia, triggering extreme blood sugar volatility. Follow the 15-minute interval strictly.

Managing the unconscious or seizing diabetic casualty¶

When an individual loses consciousness, suffers a generalized seizure, or is unable to swallow safely, never place liquids, soda, or food into their mouth. Forcing oral fluids into an unresponsive casualty leads to direct pulmonary aspiration, chemical pneumonitis, and mechanical airway obstruction.

Intranasal glucagon (Baqsimi)¶

Modern emergency care utilizes non-invasive nasal glucagon powder, which is absorbed passively across the nasal mucosa:

1. Remove the plastic shrink wrap and pull the single-dose dispenser out of the tube.
2. Hold the device with your fingers on either side of the plunger and your thumb on the base.
3. Gently insert the tip into one of the casualty nostrils until your fingers touch the outside of the nose.
4. Push the plunger completely in until the green line is no longer visible.
5. No Inhalation Required: The powder is absorbed passively through the rich nasal vascular bed. The casualty does not need to inhale, sniff, or be conscious for the medication to work. It functions even if the person has a cold or nasal congestion.

Injectable glucagon kits¶

Traditional emergency glucagon kits require manual reconstitution:

1. Flip the protective plastic cap off the vial containing powdered glucagon.
2. Remove the needle sheath from the pre-filled diluent syringe.
3. Insert the needle into the center of the rubber stopper and inject the entire volume of sterile liquid into the vial.
4. Without removing the syringe, gently swirl the vial until the powder dissolves completely into a clear, water-like solution.
5. Invert the vial and draw the solution back into the syringe (1.0 mL for adults, 0.5 mL for children under 20 kg / 44 lbs).
6. Inject intramuscularly at a 90-degree angle into the vastus lateralis (outer mid-thigh), deltoid (upper arm), or upper outer buttock.

Important glucagon limitations¶

Glucagon is not glucose. It is a peptide hormone that instructs the patient liver to break down stored glycogen into circulating glucose (glycogenolysis). Consequently:

• Glucagon will fail to work in individuals whose hepatic glycogen stores are depleted, including malnourished individuals, people suffering from chronic severe liver disease, or individuals who have consumed heavy quantities of alcohol.
• Glucagon frequently triggers severe nausea and projectile vomiting as the patient awakens. Always turn the casualty onto their side in the recovery position immediately after administration to prevent aspiration.
• Once conscious and able to swallow, provide oral carbohydrates immediately to replenish depleted liver glycogen stores.

Hyperglycemia and metabolic decompensation: DKA and HHS¶

Hyperglycemia develops slowly over twelve hours to multiple days. Left untreated, severe hyperglycemia leads to life-threatening metabolic crises:

+--------------------------------------------------------------------------+
|                  DIABETIC KETOACIDOSIS (DKA) PATHOPHYSIOLOGY             |
|                                                                          |
| Absolute Insulin Deficiency ---> Uncontrolled Adipose Lipolysis          |
|                                         |                                |
|                                         v                                |
| Massive Release of Free Fatty Acids to Liver ---> Ketone Body Synthesis  |
|                                         |                                |
|                                         v                                |
| Metabolic Acidosis & Accumulation of Acetoacetate & Beta-Hydroxybutyrate |
|                                         |                                |
|                                         v                                |
| Osmotic Diuresis (5-10 L Deficit) ---> Shock, Kussmaul Breathing, Coma   |
+--------------------------------------------------------------------------+

Diabetic Ketoacidosis (DKA) presentation¶

Predominantly occurs in Type 1 diabetes due to missed insulin, severe infection, trauma, or pump malfunction:

• Kussmaul Breathing: Deep, rapid, labored respirations through an open mouth. This is the body respiratory center attempting to blow off volatile carbon dioxide to compensate for severe metabolic ketoacidosis.
• Acetone Breath Odor: A distinctive sweet, fruity, nail-polish-remover smell on the breath caused by exhalation of volatile acetone.
• Dehydration and Polyuria: Excessive glucose spills into the urine, acting as an osmotic diuretic that pulls water and electrolytes out of the vascular tree. Patients experience extreme thirst, dry mucous membranes, sunken eyes, and severe hypovolemic dehydration (fluid deficits typically range from 5 to 10 liters).
• Gastrointestinal Symptoms: Severe abdominal pain, nausea, and persistent vomiting that frequently mimics acute appendicitis or bowel obstruction.

Hyperosmolar Hyperglycemic State (HHS) presentation¶

Predominantly occurs in older adults with Type 2 diabetes during severe physical illness, pneumonia, or dehydration:

• Extremely high blood glucose levels, frequently exceeding 33.3 mmol/L (600 mg/dL), reaching up to 55 mmol/L (1,000 mg/dL).
• Minimal ketone production because trace baseline insulin suppresses lipolysis, meaning acidosis and fruity breath are absent.
• Massive osmotic fluid deficits (often 8 to 12 liters of water loss), severe hyperosmolality, lethargy, focal neurological deficits, and coma.

Field management of hyperglycemia¶

Do not attempt to administer insulin to a patient in suspected DKA or HHS unless you are a qualified medical professional acting under direct physician orders:

• Correcting severe hyperglycemia requires aggressive intravenous fluid resuscitation and electrolyte balancing (particularly potassium replacement) prior to or alongside insulin infusion.
• Administering insulin without monitoring potassium can trigger catastrophic, fatal hypokalemic cardiac arrest.
• If the patient is alert and able to swallow, provide small, continuous sips of plain, unflavored water to combat dehydration, and transport them immediately to an emergency department.

The universal field safety rule¶

First responders frequently encounter a confused, combative, or semi-conscious diabetic patient without an available glucometer:

[Confused Diabetic Patient with NO Glucometer Available]
                           |
                           v
   [Is the Person Conscious and Able to Swallow Safely?]
                           |
            +--------------+--------------+
            |                             |
          [YES]                          [NO]
            |                             |
Administer 15 to 20 grams       Do NOT give oral food/liquid
Fast-Acting Oral Carbohydrate   Deploy Nasal or IM Glucagon
            |                   Place in Recovery Position
            v                   Dial 911 Immediately
Evaluate 15-Minute Response

Why we always treat for low blood sugar¶

If you cannot tell whether the patient has high or low blood sugar:

• Hypoglycemia is an immediate life threat: Profound hypoglycemia can cause irreversible neuronal necrosis and death within twenty to thirty minutes.
• Hyperglycemia is a chronic metabolic state: A patient in DKA has blood sugar elevated for days. Giving them 15 grams of fast-acting sugar will raise their blood glucose by a tiny fraction (for example, from 22.0 to 23.5 mmol/L, or 400 to 425 mg/dL), which causes zero acute harm.
• If hypoglycemia was the cause, that 15 grams of sugar will awaken them and save their life. Therefore, clinical guidelines mandate: always give sugar if the patient can swallow.

Capillary blood glucose meters and CGM interpretation¶

Checking blood sugar accurately prevents misdiagnosis:

Performing a sterile fingerstick test¶

1. Wash the patient hand with warm soapy water and dry thoroughly. If using an alcohol swab, allow the alcohol to air-dry completely for thirty seconds; wet alcohol dilutes the blood drop and falsely lowers the glucose reading.
2. Lance the side of the fingertip pad rather than the center, which is richer in nerve endings and more sensitive to pain.
3. Wipe away the first small drop of blood with clean gauze. The first drop contains interstitial tissue fluid that skews measurement accuracy.
4. Apply the second, well-formed drop of capillary blood to the test strip sensor.

Continuous Glucose Monitors (CGM) and interstitial lag¶

Many individuals wear continuous glucose monitors (such as Dexcom, Abbott FreeStyle Libre, or Medtronic Guardian sensors) on their arm or abdomen:

• The Interstitial Fluid Lag: CGMs measure glucose in subcutaneous interstitial fluid, not capillary blood. When blood glucose is rising or falling rapidly, CGM readings lag behind real-time arterial and capillary blood glucose by 5 to 15 minutes.
• The Golden Rule of CGMs: If a patient symptoms do not match their CGM reading, or if the CGM displays a rapid-rate arrow pointing down, always perform a physical fingerstick capillary blood test to confirm real-time systemic blood sugar before initiating clinical decisions.

The sulfonylurea prolonged hypoglycemia warning¶

Certain oral diabetes medications for Type 2 diabetes present extended, recurring danger:

• Sulfonylurea Drugs: Glipizide (Glucotrol), Glyburide (DiaBeta, Micronase), and Glimepiride (Amaryl).
• The Recurrent Hypoglycemia Trap: Unlike injected rapid-acting insulin which clears the body in two to four hours, sulfonylureas have prolonged half-lives and stimulate pancreatic beta cells to produce insulin continuously for 24 to 72 hours.
• Mandatory Transport: Any patient who experiences severe hypoglycemia while taking a sulfonylurea medication must be transported to an emergency department for at least 24 hours of continuous hospital observation and intravenous dextrose infusion. Casualties who wake up after receiving oral sugar or glucagon frequently slip back into fatal hypoglycemic comas hours later while sleeping at home.

Related emergency guides¶

• Seizures first aid and management
• Fainting and syncope evaluation
• Disabilities and medical needs emergency planning
• Emergency numbers and international dispatch

Enrolling in an accredited first aid or emergency medical responder training course provides essential practical skills to test blood glucose and administer life-saving emergency glucagon.